These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1751375)

  • 41. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in three siblings.
    Elias M; Horowitz J; Tal I; Kohn D; Flatau E
    Arch Dis Child; 1988 Jun; 63(6):644-6. PubMed ID: 3389894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
    Suvajdzić-Vuković N
    Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS). Description of a series of 35 patients].
    Martínez Francés A; Pereira A; Ordinas A
    Med Clin (Barc); 1997 Jun; 109(2):49-52. PubMed ID: 9280801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
    Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
    Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL; Jarolím P
    Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome.
    Yu F; Tan Y; Zhao MH
    Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
    Siddiqui FA; Lian EC
    J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Gasic GJ; Gasic TB; Honn KV
    Clin Exp Metastasis; 1983; 1(4):297-307. PubMed ID: 6400436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma P-selectin is increased in thrombotic consumptive platelet disorders.
    Chong BH; Murray B; Berndt MC; Dunlop LC; Brighton T; Chesterman CN
    Blood; 1994 Mar; 83(6):1535-41. PubMed ID: 7510145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
    Tatewaki W
    Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura.
    Mikes B; Sinkovits G; Farkas P; Csuka D; Schlammadinger A; Rázsó K; Demeter J; Domján G; Réti M; Prohászka Z
    Thromb Res; 2014 Apr; 133(4):616-21. PubMed ID: 24548690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.
    Wyllie BF; Garg AX; Macnab J; Rock GA; Clark WF;
    Br J Haematol; 2006 Jan; 132(2):204-9. PubMed ID: 16398654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering.
    Suehiro A; Yoshimoto H; Higasa S; Kakishita E
    Int J Hematol; 1999 Jul; 70(1):40-6. PubMed ID: 10446494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
    Sánchez Avalos JC
    Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.